Baker & McKenzie Life Sciences Conference
Topical Issues with a Global Impact
Baker & McKenzie is pleased to invite you to its conference which examines some of the topical issues affecting companies in the life sciences sector. Attendance is complimentary.
This conference will unite lawyers from across our offices in Asia-Pacific and the United States to discuss prevailing issues in a practical way. It will be ideal for professionals working in life sciences looking to gain a comprehensive understanding of the international issues affecting the industry. Our speakers will include leading international experts in their fields.
Who should attend?
In-house counsel, CEOs, finance directors, regulatory & IP managers, investment bankers and other professionals with an interest in life sciences.
Agenda
|
13:30 |
Registration |
|
14:00 |
Welcome and Introduction |
|
14:10 |
Obama Healthcare Reforms: status and prognosis |
|
14:50 |
Panel: Complying with anti-corruption laws: FCPA issues in the life sciences industries |
|
15:30 |
Panel: Product liability: lessons from USA and Asia Pacific |
|
16:10 |
Coffee break |
|
Break-out Sessions |
|
16:30 |
Stock Exchange disclosure obligations for life sciences companies |
Should clinical trials be held in Australia? |
|
17:10 |
Accessing the US capital markets |
Patent enforcement, research companies, generics, and hybrids |
|
17:50 |
Panel: Dealing with Governments in Asia Pacific - procurement and other issues |
Panel: Protection of your supply chain in the Asia-Pacific: combating counterfeits, parallel imports and unauthorized supply |
|
18:30 |
Cocktail Reception |
This is free of charge, however, space is limited so we encourage you to register early to avoid disappointment. Please contact
Katie Bury (at katie.bury@bakernet.com or on +1 312 861 1954)
for further details.